Intro
The Swiss Market Index (SMI) is Switzerland’s leading blue-chip equity benchmark. Here is how the index works, which companies shape it, how it has performed over time and how investors can gain exposure to it.
The Swiss Market Index, better known as the SMI, is the benchmark most investors associate with the Swiss stock market. It tracks 20 of the largest and most liquid companies listed in Switzerland and represents roughly three quarters of the Swiss equity market’s capitalisation.
That makes the SMI a useful barometer for Swiss equities, but understanding what moves it requires more than simply watching whether the index is up or down on a given day.
The SMI is concentrated in a relatively small number of large companies, has significant exposure to healthcare and other defensive sectors, and is calculated as a price index, meaning that the headline index does not include dividends.
These characteristics matter when investors compare the SMI with broader Swiss indices such as the SPI, or with international benchmarks such as the S&P 500.
What is the SMI Index?
The Swiss Market Index (SMI) is the main blue-chip equity index of the Swiss stock market. It contains 20 of the largest and most liquid stocks from the Swiss Performance Index (SPI).
According to SIX, the index covers approximately 75% of the capitalisation of the Swiss equity market, making it the most widely followed benchmark for large Swiss listed companies.
The index was launched on 30 June 1988 with a base value of 1'500 points.
SMI at a glance
| Feature | SMI |
|---|---|
| Full name | Swiss Market Index |
| Symbol | SMI |
| Number of constituents | 20 |
| Market | Switzerland |
| Exchange | SIX Swiss Exchange |
| Launch date | 30 June 1988 |
| Base value | 1'500 points |
| Weighting method | Free-float market capitalisation |
| Maximum constituent weight | 18% |
| Composition review | Annually, in September |
| Headline index type | Price index |
| Total-return version | SMI Total Return (SMIC) |
The index is calculated in real time during market hours. Each transaction in an SMI constituent can therefore affect the index level.
What is the SMI price today?
The level of the SMI changes continuously during SIX Swiss Exchange trading hours.
Importantly, the index level is not the price of an asset that investors can buy directly. It is a numerical representation of the combined price movements of the companies in the index.
On 16 November 2026, the SMI reached a new all-time intraday high of 15'272 points, illustrating how far the benchmark has advanced from its original base value of 1'500 in 1988.
The current level should always be checked using live or delayed market data, because the SMI moves throughout each trading session.
A rising SMI means that the weighted value of its constituents is increasing overall, while a falling SMI means that the opposite is happening. Because the largest companies have the highest weights, however, not every stock contributes equally to these movements.
How is the SMI calculated?
The SMI is weighted according to free-float market capitalisation.
In simple terms, larger companies have more influence on the index than smaller ones, but only shares that are considered freely tradable are included in the calculation.
A simplified representation is:
Company weight = free-float market capitalisation ÷ total free-float market capitalisation of the index
The SMI also applies a cap so that an individual constituent cannot permanently dominate the index. Constituent weights are capped at 18% under the current methodology.
This is particularly relevant for Switzerland because several companies, including Nestlé, Novartis and Roche, are among the largest listed businesses in Europe.
Why does the 18% cap matter?
Without a cap, the largest Swiss companies could represent an even greater share of the index.
The cap reduces concentration at the individual-stock level and helps the SMI comply with European UCITS diversification requirements.
It does not, however, eliminate sector concentration. Several of Switzerland’s largest listed companies operate in healthcare, which means one industry can still represent a substantial part of the index.

Which companies are in the SMI?
The SMI contains 20 companies. The composition is reviewed annually and can change as companies grow, shrink, merge or become more or less liquid.
Following the September 2026 index review, Galderma and Sandoz joined the SMI, while Swisscom and Kühne+Nagel left the index.
The current constituents are:
| Company | Ticker | Main sector |
|---|---|---|
| ABB | ABBN | Industrials |
| Alcon | ALC | Healthcare |
| Amrize | AMRZ | Building materials |
| Galderma | GALD | Healthcare |
| Geberit | GEBN | Industrials / building products |
| Givaudan | GIVN | Consumer ingredients |
| Holcim | HOLN | Building materials |
| Logitech | LOGN | Technology |
| Lonza | LONN | Healthcare / life sciences |
| Nestlé | NESN | Consumer staples |
| Novartis | NOVN | Healthcare |
| Partners Group | PGHN | Financials |
| Richemont | CFR | Luxury goods |
| Roche | ROP | Healthcare |
| Sandoz | SDZ | Healthcare |
| Sika | SIKA | Specialty chemicals / construction |
| Swiss Life | SLHN | Financials / insurance |
| Swiss Re | SREN | Financials / reinsurance |
| UBS Group | UBSG | Financials / banking |
| Zurich Insurance | ZURN | Financials / insurance |
Because weights change with share prices and free-float market capitalisation, the exact ranking of constituents evolves over time.
What are the biggest companies in the SMI?
Historically, Nestlé, Novartis and Roche have been among the most influential companies in the SMI.
Their size means movements in these shares can have a disproportionate impact on the overall index.
Other major contributors include companies such as UBS, Richemont, Zurich Insurance, ABB and Swiss Re, although their exact weights change over time.
This is one reason why investors should avoid interpreting the SMI as a perfectly balanced representation of the entire Swiss economy.
The index represents the largest listed companies, and many of those businesses generate a large share of their revenues outside Switzerland.

Why healthcare matters so much for the SMI
The 2026 index changes increased the SMI's healthcare exposure further.
With Galderma and Sandoz entering the benchmark, healthcare's share of the SMI rose to around 40%, according to UBS estimates around the September 2026 rebalancing.
That concentration has important implications.
Healthcare companies can behave differently from economically sensitive sectors such as industrials, consumer discretionary or technology. Pharmaceutical and healthcare revenues may be comparatively resilient during periods of weak economic growth, which can give the SMI a more defensive profile than some international benchmarks.
But concentration also creates risk.
If investors suddenly reprice the pharmaceutical sector because of regulation, drug-pricing policies, patent concerns or disappointing clinical developments, a large part of the SMI could be affected simultaneously.
In other words:
The SMI is diversified across companies, but it is less diversified across sectors than many global equity indices.
Historical performance of the SMI
The SMI has risen substantially since its launch, but the path has been anything but smooth.
The index started at 1'500 points in June 1988 and has experienced several major bull markets, crashes and recoveries since then.
Some important milestones include:
| Date / period | SMI milestone |
|---|---|
| 30 June 1988 | Launched at 1'500 points |
| January 1991 | Record low of 1'287.6 points |
| May 1997 | Exceeded 5'000 for the first time |
| March 1998 | Exceeded 7'500 |
| June 2007 | Exceeded 9'500 |
| 2000–2003 | Lost more than 50% during the dot-com bear market |
| March 2003 | Fell to around 3'675 |
| January 2018 | Reached a then-record 9'558 |
| November 2026 | Reached a new record above 15'200 |
The long-term upward trend therefore includes periods in which investors experienced very substantial drawdowns.
The dot-com crash
After the technology boom of the late 1990s, the SMI lost more than half of its value between 2000 and 2003.
The index fell to around 3'675 points in March 2003.
While Switzerland was not as technology-heavy as the US Nasdaq, the global bear market, economic uncertainty and financial-sector weakness had a major impact.
The global financial crisis
The SMI moved above 9'500 points in 2007 before the global financial crisis dramatically changed market conditions.
The collapse of Lehman Brothers in 2008 and the crisis in the banking system created enormous volatility across global equity markets, including Switzerland.
The Swiss franc shock of 2015
On 15 January 2015, the Swiss National Bank unexpectedly abandoned the minimum EUR/CHF exchange rate.
The SMI fell 8.67% in one session, one of the largest one-day declines in its history.
This episode is also a useful reminder that the SMI is affected not only by company fundamentals but also by monetary policy and currency movements.
New highs in 2026
The SMI reached new record territory again in 2026.
On 12 November, the index moved above 15'200 points, setting a new all-time high.
That does not mean every constituent performed equally. Index gains can be driven by a relatively small group of heavily weighted companies, which is why investors should look beneath the headline level.

Price return versus total return: an important distinction
One of the most important points when analysing historical SMI performance is that the headline SMI is a price index.
That means dividends paid by its constituent companies are not reinvested in the index.
For long-term investors, this matters considerably because many large Swiss companies have historically distributed meaningful dividends.
SIX therefore also calculates an SMI Total Return index, which includes the effect of reinvested dividends.
This means that:
SMI price return ≠ investor total return
When comparing long-term performance across indices, investors should always check whether they are comparing:
- price indices with price indices, or
- total-return indices with total-return indices.
Otherwise, the comparison can be misleading.
What would CHF 10'000 invested in the SMI have become?
A simple comparison between the SMI's original base value and a later index level can illustrate the scale of long-term price appreciation.
The SMI started at 1'500 points in 1988. A level of 15'000 represents roughly ten times that initial index value.
However, this should not be interpreted as the exact return on CHF 10'000 invested in an SMI-tracking product.
Why?
Because the result would depend on:
- the exact investment date,
- tracking costs,
- management fees,
- taxes,
- dividends and their reinvestment,
- the specific ETF or fund used.
A total-return index is therefore generally more appropriate than the headline SMI for assessing the long-term return an investor might have experienced.

SMI vs SPI: what is the difference?
The SMI and SPI are both important Swiss equity indices, but they measure different things.
| SMI | SPI | |
|---|---|---|
| Main purpose | Swiss blue-chip benchmark | Broad Swiss equity market benchmark |
| Number of stocks | 20 | Broad universe of Swiss-listed equities |
| Weighting | Free-float market cap, with caps | Free-float market cap |
| Company concentration | Higher | Lower |
| Sector diversification | Lower | Broader |
| Headline calculation | Price index | Performance index |
| Dividends included in headline index | No | Yes |
The SMI focuses on Switzerland's largest and most liquid companies.
The SPI, by contrast, represents a much broader part of the Swiss stock market and includes small- and mid-cap companies in addition to the large caps.
This can lead to meaningful performance differences.
For example, a strong period for Swiss mid-cap stocks may benefit the SPI more than the SMI, while a strong rally in Roche, Novartis or Nestlé can have a much larger effect on the SMI.
There is also an important methodological difference: the commonly quoted SMI is a price index, whereas the SPI is generally quoted as a performance index that includes dividends.
SMI vs S&P 500: how are they different?
The SMI and S&P 500 are both major national equity benchmarks, but their structures are very different.
The S&P 500 contains hundreds of US companies and has substantial exposure to technology.
The SMI contains only 20 stocks and has a much heavier weighting toward healthcare, consumer staples and financials.
That gives the two indices different sensitivities.
The SMI may be more sensitive to:
- pharmaceutical and healthcare developments,
- Swiss franc movements,
- European economic conditions,
- global demand for Swiss industrial and luxury products.
The S&P 500 may be more sensitive to:
- US technology valuations,
- artificial-intelligence investment,
- US monetary policy,
- domestic US growth and consumption.
Neither index is automatically "better". They simply provide exposure to different markets, companies and sector structures.
How can investors invest in the SMI?
Investors cannot buy an index directly.
Instead, they can gain exposure through financial products that use the SMI as an underlying benchmark.
Common approaches include:
SMI ETFs
Exchange-traded funds can track the performance of the SMI by holding the underlying companies or using another replication method.
ETFs can provide diversified exposure to all 20 constituents in a single transaction.
Before investing, investors should compare factors such as:
- total expense ratio,
- replication method,
- fund size and liquidity,
- dividend policy,
- tracking difference,
- trading currency.
Index funds
Traditional index funds can also replicate the SMI.
They may be suitable for investors who prefer fund subscriptions rather than exchange-traded products.
Individual SMI stocks
Investors can also build their own exposure by buying individual companies from the index.
This gives more control over allocation but removes the automatic diversification and rebalancing provided by an index-tracking product.
Structured products and derivatives
More experienced investors can access SMI exposure through structured products, futures, options and other derivatives.
These instruments can be used for investment, hedging or tactical trading, but their risk profiles can be considerably more complex than simply holding an ETF.
Investors looking for exposure to the Swiss market can explore a range of instruments available through Swissquote. Long-term investors can access ETFs, while more active or experienced investors can explore CFDs, options and futures, or leveraged products available through Swiss DOTS. These instruments differ significantly in terms of costs, leverage, risk and investment horizon, so the appropriate choice depends on the investor’s objectives and experience.
What are the advantages of investing in the SMI?
The SMI has several characteristics that can make it attractive as part of a broader portfolio.
Exposure to globally established companies
Many SMI constituents are multinational businesses with substantial revenues outside Switzerland.
The index therefore provides exposure not only to the Swiss domestic economy but also to global healthcare, consumer, industrial and financial trends.
High liquidity
The SMI contains Switzerland's largest and most actively traded stocks, making it relatively easy for financial products to replicate.
Defensive characteristics
The high weight of healthcare, consumer staples and insurance companies can sometimes make the SMI more defensive than technology-heavy benchmarks.
Swiss franc exposure
For investors whose base currency is the Swiss franc, SMI exposure can fit naturally into a CHF-denominated portfolio.
However, many constituent companies earn revenues in euros, dollars and other currencies, so their earnings remain exposed to foreign-exchange movements.
What are the main risks of the SMI?
An index can be diversified and concentrated at the same time.
The SMI spreads exposure across 20 companies, but several important risks remain.
Sector concentration
Healthcare represents a very large part of the benchmark.
Large-company concentration
The largest stocks can dominate index movements despite the 18% cap.
Geographic concentration
The SMI is a single-country equity benchmark.
Currency effects
Many SMI companies operate globally. A strong Swiss franc can reduce the CHF value of revenues and profits earned abroad.
Price-index limitation
The headline SMI excludes dividends, so it should not automatically be used as a proxy for the total return earned by long-term investors.
What moves the SMI?
Several forces can affect the index:
- company earnings,
- interest-rate expectations,
- Swiss National Bank policy,
- global economic growth,
- pharmaceutical news,
- currency movements,
- commodity prices,
- geopolitical events,
- investor risk appetite.
Because many SMI companies are global businesses, the index can rise even when the Swiss domestic economy is weak, or fall despite relatively strong Swiss economic data.
The SMI is therefore best understood as a benchmark for large Swiss-listed multinational companies, rather than a pure measure of Switzerland's domestic economy.
There is no universal answer.
The SMI can provide exposure to high-quality global companies, strong brands and industries in which Switzerland has historically built competitive advantages.
At the same time, its concentration in a limited number of stocks and sectors means that it should not automatically be considered a fully diversified equity portfolio.
For many investors, the more relevant question is therefore not whether the SMI is "good" or "bad", but:
What role should Swiss large-cap equities play within a broader portfolio?
That depends on the investor's objectives, time horizon, existing exposure, risk tolerance and currency needs.
Frequently asked questions
What does SMI stand for?
SMI stands for Swiss Market Index. It is Switzerland's main blue-chip stock-market benchmark.
How many companies are in the SMI?
The SMI contains 20 companies, selected based primarily on free-float market capitalisation and liquidity.
What are the largest companies in the SMI?
Nestlé, Novartis and Roche have historically been among the index's largest and most influential constituents. UBS, Richemont, Zurich Insurance and ABB are also major companies within the benchmark. Exact weights change over time.
Does the SMI include dividends?
The headline SMI is a price index, so it does not include reinvested dividends. SIX also calculates the SMI Total Return, which does.
What is the difference between the SMI and SPI?
The SMI contains 20 large, liquid Swiss companies. The SPI covers a much broader universe of Swiss equities, including small- and mid-cap stocks. The headline SMI is a price index, while the SPI is commonly quoted as a performance index including dividends.
How often does the SMI change?
The composition is reviewed annually, with changes normally implemented in September. Extraordinary corporate events can also affect the index between scheduled reviews.
Can I buy the SMI directly?
No. An index is a benchmark rather than a tradable security. Investors can gain exposure through products such as ETFs, index funds, structured products, futures or options.
When was the SMI created?
The SMI was launched on 30 June 1988 with a base value of 1'500 points.
What was the SMI's all-time high?
On 12 November 2026, the SMI reached a new record high of 15'200.17 points. Because market prices change continuously, investors should check current market data for the latest level.
The content in this article is provided for educational and marketing purposes only. It does not constitute investment advice or financial recommendations.







